-
2
-
-
1842633196
-
Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology
-
Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004; 25:587-610.
-
(2004)
Eur Heart J
, vol.25
, pp. 587-610
-
-
Maisch, B.1
Seferovic, P.M.2
Ristic, A.D.3
Erbel, R.4
Rienmuller, R.5
Adler, Y.6
Tomkowski, W.Z.7
Thiene, G.8
Yacoub, M.H.9
-
3
-
-
0014402559
-
Recurrent pericarditis
-
Robinson J, Brigden W. Recurrent pericarditis. Br Med J. 1968; 2:272-275.
-
(1968)
Br Med J
, vol.2
, pp. 272-275
-
-
Robinson, J.1
Brigden, W.2
-
4
-
-
25444492565
-
Recurrent pericarditis: recent advances and remaining questions
-
Shabetai R. Recurrent pericarditis: recent advances and remaining questions. Circulation. 2005; 112:1921-1923.
-
(2005)
Circulation
, vol.112
, pp. 1921-1923
-
-
Shabetai, R.1
-
5
-
-
0025038806
-
Recurrent pericarditis
-
Fowler NO. Recurrent pericarditis. Cardiol Clin. 1990; 8:621-626.
-
(1990)
Cardiol Clin
, vol.8
, pp. 621-626
-
-
Fowler, N.O.1
-
6
-
-
25444478136
-
Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial
-
Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino G, Giammaria M, Ghisio A, Belli R, Trinchero R. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005; 112:2012-2016.
-
(2005)
Circulation
, vol.112
, pp. 2012-2016
-
-
Imazio, M.1
Bobbio, M.2
Cecchi, E.3
Demarie, D.4
Demichelis, B.5
Pomari, F.6
Moratti, M.7
Gaschino, G.8
Giammaria, M.9
Ghisio, A.10
Belli, R.11
Trinchero, R.12
-
7
-
-
1542393901
-
Day-hospital treatment of acute pericarditis: a management program for outpatient therapy
-
Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, Demarie D, Ghisio A, Trinchero R. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004; 43:1042-1046.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1042-1046
-
-
Imazio, M.1
Demichelis, B.2
Parrini, I.3
Giuggia, M.4
Cecchi, E.5
Gaschino, G.6
Demarie, D.7
Ghisio, A.8
Trinchero, R.9
-
8
-
-
23944503266
-
Management, risk factors, and outcomes in recurrent pericarditis
-
Imazio M, Demichelis B, Parrini I, Cecchi E, Demarie D, Ghisio A, Belli R, Bobbio M, Trinchero R. Management, risk factors, and outcomes in recurrent pericarditis. Am J Cardiol. 2005; 96:736-739.
-
(2005)
Am J Cardiol
, vol.96
, pp. 736-739
-
-
Imazio, M.1
Demichelis, B.2
Parrini, I.3
Cecchi, E.4
Demarie, D.5
Ghisio, A.6
Belli, R.7
Bobbio, M.8
Trinchero, R.9
-
9
-
-
0036799653
-
Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy
-
Maisch B, Ristic AD, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J. 2002; 23:1503-1508.
-
(2002)
Eur Heart J
, vol.23
, pp. 1503-1508
-
-
Maisch, B.1
Ristic, A.D.2
Pankuweit, S.3
-
10
-
-
17144418474
-
Recurrent pericarditis: mysterious or not so mysterious?
-
Maisch B. Recurrent pericarditis: mysterious or not so mysterious? Eur Heart J. 2005; 26:631-633.
-
(2005)
Eur Heart J
, vol.26
, pp. 631-633
-
-
Maisch, B.1
-
11
-
-
5344235371
-
Recurrent pain without objective evidence of disease in patients with previous idiopathic or viral acute pericarditis
-
Imazio M, Demichelis B, Parrini I, Cecchi E, Pomari F, Demarie D, Gaschino G, Ghisio A, Belli R, Trinchero R. Recurrent pain without objective evidence of disease in patients with previous idiopathic or viral acute pericarditis. Am J Cardiol. 2004; 94:973-975.
-
(2004)
Am J Cardiol
, vol.94
, pp. 973-975
-
-
Imazio, M.1
Demichelis, B.2
Parrini, I.3
Cecchi, E.4
Pomari, F.5
Demarie, D.6
Gaschino, G.7
Ghisio, A.8
Belli, R.9
Trinchero, R.10
-
12
-
-
25444510637
-
Colchicine as firstchoice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial
-
Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, Ghisio A, Belli R, Trinchero R. Colchicine as firstchoice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005; 165:1987-1991.
-
(2005)
Arch Intern Med
, vol.165
, pp. 1987-1991
-
-
Imazio, M.1
Bobbio, M.2
Cecchi, E.3
Demarie, D.4
Pomari, F.5
Moratti, M.6
Ghisio, A.7
Belli, R.8
Trinchero, R.9
-
13
-
-
16544382373
-
Clinical practice. Acute pericarditis
-
Lange RA, Hillis LD. Clinical practice. Acute pericarditis. N Engl J Med. 2004; 351:2195-2202.
-
(2004)
N Engl J Med
, vol.351
, pp. 2195-2202
-
-
Lange, R.A.1
Hillis, L.D.2
-
15
-
-
0029861713
-
Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
-
Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A. 1996; 93:12445-12450.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 12445-12450
-
-
Groh, V.1
Bahram, S.2
Bauer, S.3
Herman, A.4
Beauchamp, M.5
Spies, T.6
-
16
-
-
0033618504
-
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
-
Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999; 285: 727-729.
-
(1999)
Science
, vol.285
, pp. 727-729
-
-
Bauer, S.1
Groh, V.2
Wu, J.3
Steinle, A.4
Phillips, J.H.5
Lanier, L.L.6
Spies, T.7
-
17
-
-
0037087297
-
CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity
-
Markel G, Lieberman N, Katz G, Arnon TI, Lotem M, Drize O, Blumberg RS, Bar-Haim E, Mader R, Eisenbach L, Mandelboim O. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol. 2002; 168:2803-2810.
-
(2002)
J Immunol
, vol.168
, pp. 2803-2810
-
-
Markel, G.1
Lieberman, N.2
Katz, G.3
Arnon, T.I.4
Lotem, M.5
Drize, O.6
Blumberg, R.S.7
Bar-Haim, E.8
Mader, R.9
Eisenbach, L.10
Mandelboim, O.11
-
18
-
-
33750355389
-
Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions
-
Markel G, Seidman R, Stern N, Cohen-Sinai T, Izhaki O, Katz G, Besser M, Treves AJ, Blumberg RS, Loewenthal R, Mandelboim O, Orenstein A, Schachter J. Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions. J Immunol. 2006; 177:6062-6071.
-
(2006)
J Immunol
, vol.177
, pp. 6062-6071
-
-
Markel, G.1
Seidman, R.2
Stern, N.3
Cohen-Sinai, T.4
Izhaki, O.5
Katz, G.6
Besser, M.7
Treves, A.J.8
Blumberg, R.S.9
Loewenthal, R.10
Mandelboim, O.11
Orenstein, A.12
Schachter, J.13
-
19
-
-
84862564583
-
Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions
-
Ortenberg R, Sapir Y, Raz L, Hershkovitz L, Ben Arav A, Sapoznik-Danon S, Barshack I, Avivi C, Berkun Y, Besser MJ, Ben-Moshe T, Schachter J, Markel G. Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions. Mol Cancer Ther. 2012.
-
(2012)
Mol Cancer Ther
-
-
Ortenberg, R.1
Sapir, Y.2
Raz, L.3
Hershkovitz, L.4
Ben Arav, A.5
Sapoznik-Danon, S.6
Barshack, I.7
Avivi, C.8
Berkun, Y.9
Besser, M.J.10
Ben-Moshe, T.11
Schachter, J.12
Markel, G.13
-
20
-
-
58149302763
-
Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack
-
Markel G, Seidman R, Cohen Y, Besser MJ, Sinai TC, Treves AJ, Orenstein A, Berger R, Schachter J. Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack. Immunology. 2009; 126:186-200.
-
(2009)
Immunology
, vol.126
, pp. 186-200
-
-
Markel, G.1
Seidman, R.2
Cohen, Y.3
Besser, M.J.4
Sinai, T.C.5
Treves, A.J.6
Orenstein, A.7
Berger, R.8
Schachter, J.9
-
21
-
-
0036792506
-
Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions
-
Markel G, Wolf D, Hanna J, Gazit R, Goldman-Wohl D, Lavy Y, Yagel S, Mandelboim O. Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J Clin Invest. 2002; 110:943-953.
-
(2002)
J Clin Invest
, vol.110
, pp. 943-953
-
-
Markel, G.1
Wolf, D.2
Hanna, J.3
Gazit, R.4
Goldman-Wohl, D.5
Lavy, Y.6
Yagel, S.7
Mandelboim, O.8
-
22
-
-
71849114335
-
Systemic dysregulation of CEACAM1 in melanoma patients
-
Markel G, Ortenberg R, Seidman R, Sapoznik S, Koren-Morag N, Besser MJ, Bar J, Shapira R, Kubi A, Nardini G, Tessone A, Treves AJ, Winkler E, et al. Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunol Immunother. 2010; 59:215-230.
-
(2010)
Cancer Immunol Immunother
, vol.59
, pp. 215-230
-
-
Markel, G.1
Ortenberg, R.2
Seidman, R.3
Sapoznik, S.4
Koren-Morag, N.5
Besser, M.J.6
Bar, J.7
Shapira, R.8
Kubi, A.9
Nardini, G.10
Tessone, A.11
Treves, A.J.12
Winkler, E.13
-
23
-
-
84856405473
-
Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
-
Sivan S, Suzan F, Rona O, Tamar H, Vivian B, Tamar P, Jacob S, Gal M, Michal L. Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients. Clin Dev Immunol. 2012; 2012:290536.
-
(2012)
Clin Dev Immunol
, vol.2012
-
-
Sivan, S.1
Suzan, F.2
Rona, O.3
Tamar, H.4
Vivian, B.5
Tamar, P.6
Jacob, S.7
Gal, M.8
Michal, L.9
-
24
-
-
69349104067
-
Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B
-
Paschen A, Sucker A, Hill B, Moll I, Zapatka M, Nguyen XD, Sim GC, Gutmann I, Hassel J, Becker JC, Steinle A, Schadendorf D, Ugurel S. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B. Clin Cancer Res. 2009; 15:5208-5215.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5208-5215
-
-
Paschen, A.1
Sucker, A.2
Hill, B.3
Moll, I.4
Zapatka, M.5
Nguyen, X.D.6
Sim, G.C.7
Gutmann, I.8
Hassel, J.9
Becker, J.C.10
Steinle, A.11
Schadendorf, D.12
Ugurel, S.13
-
25
-
-
84872785819
-
Serum soluble MICB (sMICB) correlates with disease progression and survival in melanoma patients
-
Wu BJ, Li WP, Qian C, Ding W, Zhou ZW, Jiang H. Serum soluble MICB (sMICB) correlates with disease progression and survival in melanoma patients. Tumour Biol. 2013; 34:565-569.
-
(2013)
Tumour Biol
, vol.34
, pp. 565-569
-
-
Wu, B.J.1
Li, W.P.2
Qian, C.3
Ding, W.4
Zhou, Z.W.5
Jiang, H.6
-
26
-
-
0034521798
-
Cytokine activation in pericardial fluids in different forms of pericarditis
-
Pankuweit S, Wadlich A, Meyer E, Portig I, Hufnagel G, Maisch B. Cytokine activation in pericardial fluids in different forms of pericarditis. Herz. 2000; 25:748-754.
-
(2000)
Herz
, vol.25
, pp. 748-754
-
-
Pankuweit, S.1
Wadlich, A.2
Meyer, E.3
Portig, I.4
Hufnagel, G.5
Maisch, B.6
-
27
-
-
0035863552
-
Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival
-
Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. Journal of clinical oncology. 2001; 19:577-583.
-
(2001)
Journal of clinical oncology
, vol.19
, pp. 577-583
-
-
Ugurel, S.1
Rappl, G.2
Tilgen, W.3
Reinhold, U.4
-
28
-
-
84863725580
-
Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma
-
Hoejberg L, Bastholt L, Johansen JS, Christensen IJ, Gehl J, Schmidt H. Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma. Melanoma Res. 2012; 22:287-293.
-
(2012)
Melanoma Res
, vol.22
, pp. 287-293
-
-
Hoejberg, L.1
Bastholt, L.2
Johansen, J.S.3
Christensen, I.J.4
Gehl, J.5
Schmidt, H.6
-
29
-
-
84872785819
-
Serum soluble MICB (sMICB) correlates with disease progression and survival in melanoma patients
-
Wu BJ, Li WP, Qian C, Ding W, Zhou ZW, Jiang H. Serum soluble MICB (sMICB) correlates with disease progression and survival in melanoma patients. Tumour Biol. 2013; 34:565-569.
-
(2013)
Tumour Biol
, vol.34
, pp. 565-569
-
-
Wu, B.J.1
Li, W.P.2
Qian, C.3
Ding, W.4
Zhou, Z.W.5
Jiang, H.6
-
30
-
-
0347479205
-
Cardiac troponin I in acute pericarditis
-
Imazio M, Demichelis B, Cecchi E, Belli R, Ghisio A, Bobbio M, Trinchero R. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol. 2003; 42:2144-2148.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 2144-2148
-
-
Imazio, M.1
Demichelis, B.2
Cecchi, E.3
Belli, R.4
Ghisio, A.5
Bobbio, M.6
Trinchero, R.7
-
31
-
-
0036385932
-
The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis
-
Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF. The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest. 2002; 122:900-905.
-
(2002)
Chest
, vol.122
, pp. 900-905
-
-
Burgess, L.J.1
Reuter, H.2
Carstens, M.E.3
Taljaard, J.J.4
Doubell, A.F.5
-
32
-
-
0036254764
-
Cytokine production in patients with tuberculous pericarditis
-
Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF. Cytokine production in patients with tuberculous pericarditis. Int J Tuberc Lung Dis. 2002; 6:439-446.
-
(2002)
Int J Tuberc Lung Dis
, vol.6
, pp. 439-446
-
-
Burgess, L.J.1
Reuter, H.2
Carstens, M.E.3
Taljaard, J.J.4
Doubell, A.F.5
-
33
-
-
20844444908
-
Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis
-
Szturmowicz M, Tomkowski W, Fijalkowska A, Kupis W, Cieslik A, Demkow U, Langfort R, Wiechecka A, Orlowski T, Torbicki A. Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis. Int J Biol Markers. 2005; 20:43-49.
-
(2005)
Int J Biol Markers
, vol.20
, pp. 43-49
-
-
Szturmowicz, M.1
Tomkowski, W.2
Fijalkowska, A.3
Kupis, W.4
Cieslik, A.5
Demkow, U.6
Langfort, R.7
Wiechecka, A.8
Orlowski, T.9
Torbicki, A.10
-
34
-
-
23344442369
-
Gene expression profiles in hypoxic preconditioning using cDNA microarray analysis: altered expression of an angiogenic factor, carcinoembryonic antigen-related cell adhesion molecule 1
-
Chen WJ, Chen HW, Yu SL, Huang CH, Wang TD, Chen JJ, Chien CT, Chen HY, Yang PC, Lee YT. Gene expression profiles in hypoxic preconditioning using cDNA microarray analysis: altered expression of an angiogenic factor, carcinoembryonic antigen-related cell adhesion molecule 1. Shock. 2005; 24:124-131.
-
(2005)
Shock
, vol.24
, pp. 124-131
-
-
Chen, W.J.1
Chen, H.W.2
Yu, S.L.3
Huang, C.H.4
Wang, T.D.5
Chen, J.J.6
Chien, C.T.7
Chen, H.Y.8
Yang, P.C.9
Lee, Y.T.10
-
35
-
-
38449113206
-
The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection
-
Kim J, Chang CK, Hayden T, Liu FC, Benjamin J, Hamerman JA, Lanier LL, Kang SM. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J Immunol. 2007; 179: 6416-6420.
-
(2007)
J Immunol
, vol.179
, pp. 6416-6420
-
-
Kim, J.1
Chang, C.K.2
Hayden, T.3
Liu, F.C.4
Benjamin, J.5
Hamerman, J.A.6
Lanier, L.L.7
Kang, S.M.8
-
36
-
-
0041737499
-
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
-
Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG, Steinle A. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood. 2003; 102:1389-1396.
-
(2003)
Blood
, vol.102
, pp. 1389-1396
-
-
Salih, H.R.1
Antropius, H.2
Gieseke, F.3
Lutz, S.Z.4
Kanz, L.5
Rammensee, H.G.6
Steinle, A.7
-
37
-
-
4344624611
-
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer
-
Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, Plymate SR. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest. 2004; 114:560-568.
-
(2004)
J Clin Invest
, vol.114
, pp. 560-568
-
-
Wu, J.D.1
Higgins, L.M.2
Steinle, A.3
Cosman, D.4
Haugk, K.5
Plymate, S.R.6
-
38
-
-
30444436170
-
Soluble MICA in malignant diseases
-
Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A, Salih HR. Soluble MICA in malignant diseases. Int J Cancer. 2006; 118:684-687.
-
(2006)
Int J Cancer
, vol.118
, pp. 684-687
-
-
Holdenrieder, S.1
Stieber, P.2
Peterfi, A.3
Nagel, D.4
Steinle, A.5
Salih, H.R.6
-
39
-
-
50949131024
-
Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis
-
Fernandez-Morera JL, Rodriguez-Rodero S, Lahoz C, Tunon A, Astudillo A, Garcia-Suarez O, Martinez-Borra J, Lopez-Vazquez A, Rodrigo L, Gonzalez S, Lopez-Larrea C. Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis. Hum Immunol. 2008; 69:235-240.
-
(2008)
Hum Immunol
, vol.69
, pp. 235-240
-
-
Fernandez-Morera, J.L.1
Rodriguez-Rodero, S.2
Lahoz, C.3
Tunon, A.4
Astudillo, A.5
Garcia-Suarez, O.6
Martinez-Borra, J.7
Lopez-Vazquez, A.8
Rodrigo, L.9
Gonzalez, S.10
Lopez-Larrea, C.11
-
40
-
-
34248187583
-
CEACAM1, a novel serum biomarker for pancreatic cancer
-
Simeone DM, Ji B, Banerjee M, Arumugam T, Li D, Anderson MA, Bamberger AM, Greenson J, Brand RE, Ramachandran V, Logsdon CD. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas. 2007; 34:436-443.
-
(2007)
Pancreas
, vol.34
, pp. 436-443
-
-
Simeone, D.M.1
Ji, B.2
Banerjee, M.3
Arumugam, T.4
Li, D.5
Anderson, M.A.6
Bamberger, A.M.7
Greenson, J.8
Brand, R.E.9
Ramachandran, V.10
Logsdon, C.D.11
-
41
-
-
47749131140
-
NKG2D ligands: key targets of the immune response
-
Gonzalez S, Lopez-Soto A, Suarez-Alvarez B, Lopez-Vazquez A, Lopez-Larrea C. NKG2D ligands: key targets of the immune response. Trends Immunol. 2008; 29:397-403.
-
(2008)
Trends Immunol
, vol.29
, pp. 397-403
-
-
Gonzalez, S.1
Lopez-Soto, A.2
Suarez-Alvarez, B.3
Lopez-Vazquez, A.4
Lopez-Larrea, C.5
-
42
-
-
33644842918
-
Placentaderived soluble MHC class I chain-related molecules down regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival
-
Mincheva-Nilsson L, Nagaeva O, Chen T, Stendahl U, Antsiferova J, Mogren I, Hernestal J, Baranov V. Placentaderived soluble MHC class I chain-related molecules down regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J Immunol. 2006; 176:3585-3592.
-
(2006)
J Immunol
, vol.176
, pp. 3585-3592
-
-
Mincheva-Nilsson, L.1
Nagaeva, O.2
Chen, T.3
Stendahl, U.4
Antsiferova, J.5
Mogren, I.6
Hernestal, J.7
Baranov, V.8
-
43
-
-
0041422233
-
Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis
-
Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2003; 100:9452-9457.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 9452-9457
-
-
Groh, V.1
Bruhl, A.2
El-Gabalawy, H.3
Nelson, J.L.4
Spies, T.5
-
44
-
-
0037126310
-
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
-
Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 2002; 419:734-738.
-
(2002)
Nature
, vol.419
, pp. 734-738
-
-
Groh, V.1
Wu, J.2
Yee, C.3
Spies, T.4
-
45
-
-
0022967403
-
Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy
-
Maisch B. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy. Basic Res Cardiol. 1986; 81:217-241.
-
(1986)
Basic Res Cardiol
, vol.81
, pp. 217-241
-
-
Maisch, B.1
|